Synergistic effect of cholecystokinin octapeptide and angiotensin II in reversal of morphine induced analgesia in rats

Pain

Volumn 85, Issue 3, 2000, Pages 465-469

  Han, Nian Lin ^a   Luo, Fei ^a   Bian, Zhu Ping ^b   Han, Ji Sheng ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Yian Bei Nursing School Datong PR   (China)

Author keywords

Angiotensin II; Cholecystokinin octapeptide; Intracerebroventricular injection; Morphine induced analgesia; Synergistic effect

Indexed keywords

ANGIOTENSIN; CHOLECYSTOKININ OCTAPEPTIDE; MORPHINE;

ANALGESIA; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; INFORMATION PROCESSING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANGIOTENSIN II; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHINE; PAIN MEASUREMENT; RATS; RATS, WISTAR; SINCALIDE; VASOCONSTRICTOR AGENTS;

EID: 0034175484     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00294-8     Document Type: Article

References (27)

1. Beinfeld M.C. Cholecystokinin in the central nervous system: a mini review. Neuropeptides. 3:1983;411-427.
2. Berenbaum M.C. What is synergy? Pharmacol Rev. 41:1989;93-141.
3. Faris P.L., Komisaruk B.R., Watkins L.R., Mayer D.J. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 219:1983;310-312.
4. Fields H.L., Emson P.C., Leigh B.K., Gilbert R.F.T., Iversen L.L. Multiple opiate receptor-sites on primary afferent fibers. Nature (Lond). 284:1980;351-353.
5. Fujimoto J.M., Arts K.S., Rady J.J., Tseng L.F. Spinal dynorphin A (1-17): possible mediator of antianalgesia action. Neuropharmacology. 29:1990;609-617.
6. Gebhart G.F. Editorial comment - topical reviews: a new type of report in PAIN. Pain. 49:1992;1.
7. Han J.S., Ding X.Z., Fan S.G. Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous anti-opioid substrates? Neuropeptides. 5:1985;399-402.
8. Kaneko S., Tamura S., Takagi H. Purification and identification of endogenous anti-opioid substances from bovine brain. Biochem Biophys Res Commun. 126:1985;587-593.
9. Kimberly A.S., Miaskowski C., Taiwo Y.O., Levine J.D. Analgesic synergy and improved motor function produced by combination of μ-δ and μ-κ-opioids. Brain Res. 530:1990;290-294.
10. Litchfield J.T., Wilcoxon F.A. Simplified method of evaluating dose effect experiments. J Pharmacol Exp Ther. 96:1949;99-113.
11. Ma Q.P., Shi Y.S., Han J.S. Further studies on interactions between periaqueductal gray, nucleus accumbens and habenula in antinociception. Brain Res. 583:1992;292-295.
12. Miaskowski C., Sutter K.A., Taiwo Y.O., Levine J.D. Antinociceptive and motor effect of delta/mu and kappa/mu combinations of intrathecal opioid agonists. Pain. 49:1992;137-144.
13. Muscha-Steekelings U., Unger T. Angiotensin receptor subtypes in the brain. Trends Pharm Sci. 13:1992;365-368.
14. Pellegrino L.J., Pellegrino A.S., Cushman A.J. A stereotaxic atlas of the rat brain. 1979;Plenum Press, New York.
15. Raizada M.K., Lu D., Tang W., Kurian P., Sumners C. Increased angiotensin II type-1 receptor gene expression in neuronal cultures from spontaneously hypertensive rats. Endocrinology. 132:1993;1715-1722.
16. Ren M.F., Han J.S. Rat tail flick acupuncture analgesia model. Chinese Med J. 92:1979;576-582.
17. Tallarida R.J. Statistical analysis of drug combinations for synergism. Pain. 49:1992;93-97.
18. Wang X.M., Han J.S. Antagonism to morphine analgesia and involvement in morphine tolerance of angiotensin II in periaqueductal gray of the rabbits. Chinese J Pharmacol. 10:1989;294-297.
19. Wang K.W., Han J.S. Accelerated synthesis and release of angiotensin II in the rat brain during electroaccupuncture tolerance. Sci China Bull. 33:1990;686-693.
20. Wang X.J., Han J.S. Modification by cholecystokinin octapeptide of the binding of mu, delta and kappa-opioid receptor. J Neurochem. 55:1990;1379.
21. Wang J.F., Ren M.F., Han J.S. Mobolization of calcium from intracellular stores as one of the mechanisms underlying the antiopioid effect of CCK-8. Peptides. 13:1992;947-951.
22. Wang J.F., Sun X.J., Yang H.F., Ren M.F., Han J.S. Mobilization of calcium from intracellular store as a possible mechanism underlying the anti-opioid effect of angiotensin II. Neuropeptides. 22:1992;219-222.
23. Werz M.A., Grega D.S., MacDonald R.L. Actions of mu, delta and kappa opioid agonists and antagonists on mouse primary afferent neurons in culture. J Pharmacol Exp Ther. 243:1987;258-263.
24. Xu T., Liu N.J., Li C.Q., Shangguan Y., Yu Y.X., Kang H.G., Han J.S. Cholecystokinin octapeptide reverses the kappa-opioid-receptor-mediated depression of calcium current in rat dorsal root ganglion neurons. Brain Res. 730:1996;207-211.
25. Zhang L.J., Lu X.Y., Han J.S. Influences of cholecystokinin octapeptide on phosphoinositide turnover in neonatal rat brain cells. Biochem J. 285:1992;847-850.
26. Zhou Z.F., Xuan Y.T., Han J.S. Analgesic effect of morphine injected into habenula, nuleus accumbens and amygdala of rabbits. Acta Pharmacol Sin. 5:1984;150-153.
27. Zhou Y., Sun Y.H., Zhang Z.W., Han J.S. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365. 260 in rat spinal cord. Eur J Pharmacol. 324:1993;147-154.